Equities

Craneware PLC

Craneware PLC

Actions
Health CareHealth Care Providers
  • Price (GBX)2,100.00
  • Today's Change90.00 / 4.48%
  • Shares traded273.78k
  • 1 Year change+30.43%
  • Beta0.6252
Data delayed at least 20 minutes, as of Nov 08 2024 14:51 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Craneware PLC grew revenues 8.76% from 174.02m to 189.27m while net income improved 26.77% from 9.23m to 11.70m.
Gross margin85.70%
Net profit margin6.18%
Operating margin10.43%
Return on assets2.09%
Return on equity3.57%
Return on investment2.77%
More ▼

Cash flow in USDView more

In 2024, cash reserves at Craneware PLC fell by 43.95m. However, the company earned 41.86m from its operations for a Cash Flow Margin of 22.12%. In addition the company used 15.81m on investing activities and also paid 70.00m in financing cash flows.
Cash flow per share0.9887
Price/Cash flow per share21.38
Book value per share7.20
Tangible book value per share-2.39
More ▼

Balance sheet in USDView more

Craneware PLC has a Debt to Total Capital ratio of 10.89%, a lower figure than the previous year's 23.58%.
Current ratio0.6267
Quick ratio--
Total debt/total equity0.1222
Total debt/total capital0.1089
More ▼

Growth rates in USD

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 1.26% and 27.28%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Software & Programming industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is in-line with the industry average relative to its peers, while earnings per share growth is below the industry average.
Div yield(5 year avg)1.49%
Div growth rate (5 year)2.13%
Payout ratio (TTM)49.15%
EPS growth(5 years)-9.62
EPS (TTM) vs
TTM 1 year ago
27.16
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.